Pay in installments of $5.79 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 15 - Jul 20
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Retatrutide GLP 3 Advanced Triple Agonist Weight Loss Calibrate IV OZEMPIC NAUSEA 10 Ways to Prevent & Treat Your Side Effects How To Get an Ozempic Prescription Online In Canada Felix Do you need to stay on Ozempic forever? Dr Debra Marcos reveals what's 'setting patients up to fail' The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in India on March 20, opening the door for a wave of low cost Semaglutide Weight Loss: Sarah's Family 40 Pound Transformation and What You Need Mind blowing to Know SkyNet Worldwide Express
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.3 ★★★★★
Based on 20 reviews
Sort
Product Reviews
★★★★★ 5
One of the essential references for scholars and humanists
Format: Paperback
I got the 1972 PEPP as a high school student (and self-imposed "poet"). I was cured of being a poet by time, but reading through PEPP like an evergreen sampler plate made me educated in prosody, forms, theories of poetry, the history of genres, national literatures, and more. When I went to college, my professors kept asking which expensive prep school I had gone to, because no one came as well prepared as I was. The NPEPP was not quite as inspiring, but this edition is thrilling. Get it. Open it and start grazing. This is not a book as much as it is a field to wander in for years. It works as traditional reference -- answering questions on specific lemma -- but it also works as a delightful resource.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 7, 2018
★★★★★ 5
Excellent Reference Book!
Format: Paperback
I don't think this book was meant to be read cover to cover. If it is, the reader better start reading at an early age because there are over 1,000 pages and print is small. However, the book is an excellent reference and provides data that other similar books do not cover. It is a worthy investment.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 8, 2024
★★★★★ 5
Comprehensive beyond words.
Format: Paperback, Format: Paperback
A very comprehensive reference on poetry. A budding poet should not live without a copy of this work of more than four decades.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 31, 2019
★★★★★ 4
The definitive reference
Format: Kindle
The definitive reference. It can be a bit hard to use if you're not up on the jargon, but it's an invaluable work if you are interested in the technical aspects of poetics.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 27, 2016
★★★★★ 5
This vital work for poets, critics of poetry, ...
Format: Paperback
This vital work for poets, critics of poetry, and literature specialists receives a hearty update making it even more relevant for users. No serious poet or student of poetry and literature can live without it. It is a necessary reference.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 11, 2017
recommand products
Sodium glucose cotransport 2 (SGLT-2) inhibitors and glucagon-like
24.67
How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?
29.94
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar
24.58
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
27.22
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome
21.67